Piscataqua Savings Bank’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AVM
MM
Piscataqua Savings Bank's BEAM Position: Q3 2024 in Review
Piscataqua Savings Bank sold out of Beam Therapeutics (BEAM) in Q3 2024, closing a stake of 50 shares — an estimated $1.17K sold.
Piscataqua Savings Bank first reported a position in BEAM in Q1 2022 and held it in 10 quarters. The position peaked at $3K in Q1 2022. 221 funds tracked by Wall St. Rank hold BEAM as of Q3 2024.
- Piscataqua Savings Bank reported no remaining Beam Therapeutics position as of Q3 2024 after selling out during the quarter.
- Piscataqua Savings Bank sold 50 Beam Therapeutics shares in Q3 2024, an estimated $1.17K.
- Piscataqua Savings Bank first reported a position in Beam Therapeutics in Q1 2022 and held it in 10 quarters.
- Piscataqua Savings Bank's Beam Therapeutics position peaked at $3K in Q1 2022.
- 221 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2024.
Based on Piscataqua Savings Bank's 13F filing for Q3 2024, filed 15 Oct 2024.